Whalesbook
The Indian government is considering global tenders for over 65 patented drugs, including essential medicines for weight-loss, cancer, cardiac, and diabetes, due to limited domestic manufacturing capabilities. This move aims to ensure timely patient access through central healthcare establishments like the armed forces and ESIC, potentially creating exemptions from the policy favoring local industries. Local manufacturers have a chance to raise objections.